Ligand Pharmaceuticals
LGND
#3601
Rank
โ‚ฌ3.12 B
Marketcap
158,78ย โ‚ฌ
Share price
-1.93%
Change (1 day)
34.39%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ0.38 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total debt is โ‚ฌ0.38 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Ligand Pharmaceuticals - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ6.82 M22.43%
2023-12-31โ‚ฌ5.57 M-93.18%
2022-12-31โ‚ฌ81.8 M-71.44%
2021-12-31โ‚ฌ0.28 B-22.81%
2020-12-31โ‚ฌ0.37 B-36.07%
2019-12-31โ‚ฌ0.58 B4.35%
2018-12-31โ‚ฌ0.55 B197.23%
2017-12-31โ‚ฌ0.18 B-7.55%
2016-12-31โ‚ฌ0.20 B9.57%
2015-12-31โ‚ฌ0.18 B14.68%
2014-12-31โ‚ฌ0.16 B2342.14%
2013-12-31โ‚ฌ6.59 M-69.15%
2012-12-31โ‚ฌ21.37 M-8.33%
2011-12-31โ‚ฌ23.32 M35.75%
2010-12-31โ‚ฌ17.17 M-32.15%
2009-12-31โ‚ฌ25.31 M-31.31%
2008-12-31โ‚ฌ36.86 M2397.47%
2007-12-31โ‚ฌ1.47 M-95.37%
2006-12-31โ‚ฌ31.88 M-78.16%
2005-12-31โ‚ฌ0.14 B13.79%
2004-12-31โ‚ฌ0.12 B-6.39%
2003-12-31โ‚ฌ0.13 B-8.95%
2002-12-31โ‚ฌ0.15 B-6.47%
2001-12-31โ‚ฌ0.16 B12.15%
2000-12-31โ‚ฌ0.14 B2.56%
1999-12-31โ‚ฌ0.13 B77.21%
1998-12-31โ‚ฌ78.96 M72.88%
1997-12-31โ‚ฌ45.67 M-4.24%
1996-12-31โ‚ฌ47.69 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
โ‚ฌ46.88 B 12,003.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚ฌ24.77 M-93.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ20.49 B 5,190.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ35.53 B 9,073.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ52.26 B 13,391.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ36.50 B 9,325.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ43.83 B 11,217.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ8.34 B 2,053.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ39.33 B 10,054.17%๐Ÿ‡บ๐Ÿ‡ธ USA